경동맥 스텐트 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Carotid Artery Stents Market size is expected to reach USD 910.57 Million in 2034 from USD 664.64 Million (2025) growing at a CAGR of 3.56% during 2026-2034.

The Global Carotid Artery Stents Market is growing steadily due to the rising incidence of cardiovascular diseases and stroke worldwide. Carotid artery stenting is a minimally invasive procedure used to prevent stroke by treating carotid artery stenosis. Increasing preference for minimally invasive surgical techniques and improved patient outcomes are driving adoption. Technological advancements in stent design and imaging guidance systems further enhance procedural safety and effectiveness.

Key growth drivers include aging populations, sedentary lifestyles, and increasing hypertension and cholesterol levels. Healthcare providers are emphasizing early diagnosis and preventive cardiovascular treatments. Improvements in biocompatible materials and embolic protection devices have strengthened clinical outcomes. Additionally, expanding healthcare infrastructure and reimbursement policies in developed economies are supporting the adoption of advanced stenting procedures.

Future prospects indicate strong growth with innovation in next-generation drug-eluting stents and improved catheter systems. Emerging markets are expected to offer growth opportunities due to rising awareness and expanding cardiac care facilities. Continuous clinical research and regulatory approvals for advanced devices will further stimulate demand. As stroke prevention remains a healthcare priority, the carotid artery stents market is likely to experience sustained global expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

• Drug Eluting Stents
• Bare Metal Stents
• Bioabsorbable Stents

By Material

• Metals
• Polymers

By Mode of Delivery

• Balloon-expandable Stents
• Self-expanding Stents

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• Abbott Laboratories Inc, Balton Sp z oo, Boston Scientific Corporation, Cordis, InspireMD Inc, Medtronic plc, Terumo Europe NV, MicroPort Scientific Corporation, Silk Road Medical Inc, Cardinal Health Inc
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CAROTID ARTERY STENTS MARKET: BY TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Type
• 4.2. Drug Eluting Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Bare Metal Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Bioabsorbable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CAROTID ARTERY STENTS MARKET: BY MATERIAL 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Material
• 5.2. Metals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Polymers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CAROTID ARTERY STENTS MARKET: BY MODE OF DELIVERY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Mode Of Delivery
• 6.2. Balloon-expandable Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Self-expanding Stents Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CAROTID ARTERY STENTS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CAROTID ARTERY STENTS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Type
  • 8.2.2 By Material
  • 8.2.3 By Mode Of Delivery
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Type
  • 8.3.2 By Material
  • 8.3.3 By Mode Of Delivery
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Type
  • 8.4.2 By Material
  • 8.4.3 By Mode Of Delivery
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Type
  • 8.5.2 By Material
  • 8.5.3 By Mode Of Delivery
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Type
  • 8.6.2 By Material
  • 8.6.3 By Mode Of Delivery
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CAROTID ARTERY STENTS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Abbott Laboratories Inc
  • 10.2.2 Balton Sp Z O.O
  • 10.2.3 Boston Scientific Corporation
  • 10.2.4 Cordis
  • 10.2.5 InspireMD Inc
  • 10.2.6 Medtronic Plc
  • 10.2.7 Terumo Europe NV
  • 10.2.8 MicroPort Scientific Corporation
  • 10.2.9 Silk Road Medical Inc
  • 10.2.10 Cardinal Health Inc